personalised medicine

Oncology

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

News

An MHRA document explaining how regulations will adapt to the era of AI and personalised medicine has been well received by the pharma industry.

News

Federal funding from ARPA-H of $125m, awarded to five groups, is part of a drive to accelerate patient access to personalised genetic medicines.

News

Researchers have used a machine learning algorithm to try to work out why Parkinson's disease patients can respond so differently to treatment.

News

A scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems.

Patients

Discover what clinicians can do to foster more patient-centred psychiatric care in a Q&A with neuropsychiatric physician assistant Rebecca Barbee.